Drug Profile
SKP 450
Alternative Names: KR 30450Latest Information Update: 26 Mar 2008
Price :
$50
*
At a glance
- Originator Korea Research Institute of Chemical Technology
- Developer SK Pharma
- Class Benzopyrans; Dioxolanes; Pyrrolidinones; Small molecules
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension; Myocardial ischaemia